[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO169346C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser

Info

Publication number
NO169346C
NO169346C NO881746A NO881746A NO169346C NO 169346 C NO169346 C NO 169346C NO 881746 A NO881746 A NO 881746A NO 881746 A NO881746 A NO 881746A NO 169346 C NO169346 C NO 169346C
Authority
NO
Norway
Prior art keywords
androst
cyclopropylamino
17beta
3beta
ols
Prior art date
Application number
NO881746A
Other languages
English (en)
Norwegian (no)
Other versions
NO881746L (no
NO881746D0 (no
NO169346B (no
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO881746D0 publication Critical patent/NO881746D0/no
Publication of NO881746L publication Critical patent/NO881746L/no
Publication of NO169346B publication Critical patent/NO169346B/no
Publication of NO169346C publication Critical patent/NO169346C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
NO881746A 1987-04-22 1988-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser NO169346C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4117287A 1987-04-22 1987-04-22

Publications (4)

Publication Number Publication Date
NO881746D0 NO881746D0 (no) 1988-04-21
NO881746L NO881746L (no) 1988-10-24
NO169346B NO169346B (no) 1992-03-02
NO169346C true NO169346C (no) 1992-06-10

Family

ID=21915133

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881746A NO169346C (no) 1987-04-22 1988-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser

Country Status (19)

Country Link
EP (1) EP0288053B1 (fi)
JP (1) JP2711672B2 (fi)
KR (1) KR960015037B1 (fi)
CN (1) CN88102176A (fi)
AT (1) ATE67211T1 (fi)
AU (1) AU606677B2 (fi)
CA (1) CA1326234C (fi)
DE (1) DE3864725D1 (fi)
DK (1) DK217588A (fi)
ES (1) ES2038712T3 (fi)
FI (1) FI88397C (fi)
GR (1) GR3002713T3 (fi)
HU (1) HU198511B (fi)
IL (1) IL86139A (fi)
NO (1) NO169346C (fi)
NZ (1) NZ224288A (fi)
PH (1) PH24090A (fi)
PT (1) PT87294B (fi)
ZA (1) ZA882717B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
NZ249911A (en) * 1992-03-31 1996-06-25 British Tech Group 17-(3-pyridyl) substituted steroids and use in pharmaceutical compositions
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
WO2002040484A2 (en) 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Novel imidazole derivatives, production method thereof and use thereof
WO2002040470A1 (fr) 2000-11-20 2002-05-23 Takeda Chemical Industries, Ltd. Derives de l'imidazole, leur procede de preparation et leur application
WO2002046186A1 (fr) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation
RS53384B (en) 2009-06-26 2014-10-31 Novartis Ag DERIVATIVES OF 1,3-DISUPSTITUTED IMIDAZOLIDIN-2-ON AS CYP 17 INHIBITORS
CA2807149C (en) 2010-08-04 2017-05-02 Pellficure Pharmaceuticals, Inc. Novel treatment of prostate carcinoma
WO2012035078A1 (en) 2010-09-16 2012-03-22 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
EP2702052B1 (en) 2011-04-28 2017-10-18 Novartis AG 17alpha-hydroxylase/c17,20-lyase inhibitors
CA2902335C (en) 2013-03-14 2021-09-14 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
EP3528799A1 (en) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302932A (fi) * 1962-12-31
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
CA1326234C (en) 1994-01-18
KR880012633A (ko) 1988-11-28
IL86139A (en) 1993-02-21
NO881746L (no) 1988-10-24
NZ224288A (en) 1989-12-21
EP0288053B1 (en) 1991-09-11
GR3002713T3 (en) 1993-01-25
PT87294A (pt) 1988-05-01
DK217588A (da) 1988-10-23
NO881746D0 (no) 1988-04-21
DE3864725D1 (de) 1991-10-17
FI881877A0 (fi) 1988-04-21
AU1471988A (en) 1988-10-27
JPS63284195A (ja) 1988-11-21
HU198511B (en) 1989-10-30
FI88397B (fi) 1993-01-29
FI88397C (fi) 1993-05-10
IL86139A0 (en) 1988-11-15
HUT47307A (en) 1989-02-28
ATE67211T1 (de) 1991-09-15
DK217588D0 (da) 1988-04-21
AU606677B2 (en) 1991-02-14
EP0288053A1 (en) 1988-10-26
PT87294B (pt) 1992-08-31
CN88102176A (zh) 1988-11-23
ZA882717B (en) 1988-10-17
PH24090A (en) 1990-03-05
NO169346B (no) 1992-03-02
KR960015037B1 (ko) 1996-10-24
ES2038712T3 (es) 1993-08-01
FI881877A (fi) 1988-10-23
JP2711672B2 (ja) 1998-02-10

Similar Documents

Publication Publication Date Title
NO169346C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser
NO903564D0 (no) Fremgangsmaate for fremstilling av 4-substituerte 17beta-(cyklopropylamino)androst-5-en-3beta-ol-derivater.
LTIP919A (en) Drugs and process for preparing thereof
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
NO168892C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropyloxy)androst-5-en-3beta-ol-derivater
ZA79964B (en) 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
NO166282C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt kalsium-9-etyl-6,9-dihydro-4,6-diokso-10-propyl-4h-(3,2-g)-kinolin-2,8-di-karboksylat.
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
IE900303L (en) 18-cyanoprogesterone derivatives